SCHEMBL20041788

SCHEMBL20041788

CCCCCCCc1ncc(C)cn1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 1/20 0.41
MAPT P10636 2/20 0.39
RAB9A P51151 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
KDM4E B2RXH2 2/20 0.39
ALDH1A1 P00352 2/20 0.39
HSD17B10 Q99714 2/20 0.39
MEN1 O00255 1/20 0.39
USP2 O75604 1/20 0.39
GAA P10253 1/20 0.39
HPGD P15428 1/20 0.39
KMT2A Q03164 1/20 0.39
TDP1 Q9NUW8 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
NPC1 O15118 1/20 0.37
STAT3 P40763 1/20 0.37
ATM Q13315 1/20 0.37
PTGS2 P35354 3/20 0.36
ESR1 P03372 2/20 0.36
ADRA2A P08913 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19185731 1.00 KCNH2 (0.41) KCNH2MAPTRAB9ASMN1; SMN2KDM4E
SCHEMBL19185634 1.00 KCNH2 (0.41) KCNH2MAPTRAB9ASMN1; SMN2KDM4E
SCHEMBL12527781 0.98 L3MBTL1 (0.38) KCNH2MAPTRAB9ASMN1; SMN2KDM4E
SCHEMBL19185580 0.91 NOS2 (0.38) MAPTRAB9ASMN1; SMN2KDM4EALDH1A1
SCHEMBL11976549 0.83 RAB9A (0.39) KCNH2MAPTRAB9ASMN1; SMN2KDM4E
SCHEMBL28055917 0.83 RARB (0.50) MAPTRAB9ASMN1; SMN2KDM4EALDH1A1
SCHEMBL12457576 0.81 DHFR (0.35) MAPTKDM4EALDH1A1USP2GAA
SCHEMBL13402169 0.81 MEN1 (0.55) MAPTRAB9ASMN1; SMN2ALDH1A1MEN1
SCHEMBL17967585 0.81 RAB9A (0.57) KCNH2MAPTRAB9ASMN1; SMN2KDM4E
SCHEMBL15894460 0.81 RAB9A (0.41) KCNH2MAPTRAB9ASMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2509955-B1 PYRAZOLE DERIVATIVES AS MODULATORS OF CALCIUM RELEASE-ACTIVATED CALCIUM CHANNEL RHIZEN PHARMACEUTICALS S A (CH) 2018-04-25 EP disclosed
EP-2509974-B1 PYRAZOLES DERIVATIVES MODULATORS OF CALCIUM RELEASE-ACTIVATED CALCIUM CHANNEL AND METHODS FOR TREATMENT OF NON-SMALL CELL LUNG CANCER RHIZEN PHARMACEUTICALS S A (CH) 2018-04-11 EP disclosed